节点文献

基因病毒治疗系统CNHK300-mIFN-γ治疗肝癌的实验研究

Treatment of hepatocellular carcinoma with gene-viral therapeutic system CNHK300-mIFN-γ

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 彭林辉周杰霍枫詹世林张琪苏长青钱其军

【Author】 PENG Lin-hui,ZHOU Jie,HUO Feng,ZHAN Shi-lin,ZHANG Qi,SU Chang-qing,QIAN Qi-jun.Department of Hepatobiliary Surgery,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China

【机构】 南方医科大学南方医院肝胆外科广州军区广州总医院肝胆外科中山大学附属第三医院肝脏病医院实验室第二军医大学东方肝胆外科医院病毒和基因治疗中心

【摘要】 目的比较基因病毒治疗系统CNHK300-mIFN-γ(以下简称CNHK300-Mγ)与单纯病毒治疗(CNHK300)或基因治疗(AdEasy-mIFN-γ,以下简称AdEasy-Mγ)对裸鼠移植瘤的抑瘤差异。方法观察CNHK300-Mγ、CNHK300和AdEasy-Mγ在裸鼠肝癌SMMC-7721动物模型中的抑瘤差异,并用ELISA法检测血清中mIFN-γ的表达量,HE染色观察肿瘤坏死情况,免疫组织化学染色观察肿瘤内腺病毒外壳蛋白表达情况和肿瘤内微血管生成情况。结果 CNHK300-Mγ具有明显的肿瘤生长抑制作用,与CNHK300、AdEasy-Mγ和对照组的差异均有统计学意义(P<0.05);CNHK300-Mγ组中HE染色肿瘤内见大片坏死,免疫组织化学染色肿瘤内见大量腺病毒外壳蛋白,肿瘤微血管生长明显受抑制,与CNHK300、AdEasy-Mγ和对照组的差异均有统计学意义(P<0.01)。结论基因病毒治疗系统对肿瘤细胞的杀伤能力提高,CNHK300-Mγ能明显抑制肿瘤生长,具有良好的临床应用前景。

【Abstract】 Objective To investigate the anti-tumor efficacy of a novel gene-viral therapeutic system CNHK300-mIFN-γ(CNHK300-Mγ) in hepatocellular carcinoma(HCC) xenografts. Methods Cancer cells in log phase were subcutaneously injected into the right flanks of BALB/c nude mice,with administration of 5×106 SMMC-7721 per mouse.When SMMC-7721 tumors reached about 50 mm3,mice were allocated randomly into 4 groups: CNHK300-Mγ,CNHK300,AdEasy-Md and control groups(n=16).Five intratumoral injections,once every other day,were carried out in subjects,with a total dosage of 109 pfu per mouse in the virus-treated groups and with 100 μL viral preservation solution per mouse per injection in the control group.On the 3rd and 7th day after treatment,groups of 3 mice were sacrificed for collection of serum by retroorbital puncture.ELISA was used for assessment of mIFN-γ.H&E staining and immunohistochemistry were applied for assessment of tumor necrosis and the expression of adenoviral capsid protein hexon,respectively. Results CNHK300-Mγ exhibited excellent therapeutic efficacy with tumor inhibition rate,which was significantly higher than that in CNHK300,AdEasy-Mγ and control groups(P<0.05).Extensive necrotic foci in pathologic examination were revealed in tumor tissues of CNHK300-Mγ group,compared with those of control group.There were abundant adenoviral capsid protein positive cancer cells in the CNHK300-Mγ group,whereas none was observed in the control group.Meanwhile,significant inhibition of microvessel density was revealed in CNHK300-Mγ group,when compared with those in CNHK300,AdEasy-Mγ and control groups(P<0.05). Conclusion CNHK300-Mγ can effectively suppress HCC growth through direct viral killing effects and inhibition of tumor angiogenesis,holding a splendid future as a potential antitumor agent.

【关键词】 腺病毒端粒酶基因治疗肿瘤γ干扰素
【Key words】 adenovirustelomerasegene-therapycarcinomainterferon-γ
【基金】 国家自然科学基金国际合作重大项目(编号:03102160823);高等学校全国优秀博士论文作者专项资金资助项目(编号:200774)
  • 【文献出处】 广东医学 ,Guangdong Medical Journal , 编辑部邮箱 ,2011年22期
  • 【分类号】R735.7
  • 【下载频次】65
节点文献中: 

本文链接的文献网络图示:

本文的引文网络